person · Reporting owner
Pellegrino Joseph P JR
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | September 03, 2026 | September 08, 2026 |
| PRECISION OPTICS CORPORATION, INC.POCI · Entity 7237 | Director | November 17, 2025 | November 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 25.4682 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 25.4682 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 24.7852 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 24.7852 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 30.34 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 3.6322 · Balance 30.34 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 32.3815 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 4.3524 · Balance 32.3815 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 22.6745 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 3.9442 · Balance 22.6745 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 23.0295 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 4.4688 · Balance 23.0295 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 4.2988 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
PRECISION OPTICS CORPORATION, INC.
Report date November 17, 2025 · Filed November 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Rights to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.33 · Expires 2035-11-17 | Direct | 30,000 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 30,000 · Balance 30,000 F1: The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2025 Filed Sep 8, 2025 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.2906 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028581 · rdgdoc.xml · derivative · entry 6 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27.2657 Underlying: Common Stock · 4.2906 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.5808 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028581 · rdgdoc.xml · derivative · entry 5 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.8906 Underlying: Common Stock · 3.5808 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.7926 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028581 · rdgdoc.xml · derivative · entry 4 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34.1213 Underlying: Common Stock · 2.7926 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.7926 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028581 · rdgdoc.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34.8043 Underlying: Common Stock · 2.7926 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.3714 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028581 · rdgdoc.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.3792 Underlying: Common Stock · 1.3714 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.7211 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028581 · rdgdoc.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.1959 Underlying: Common Stock · 0.7211 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.1273 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019162 · rdgdoc.xml · derivative · entry 7 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.1049 Underlying: Common Stock · 4.1273 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5.1249 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019162 · rdgdoc.xml · derivative · entry 6 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22.9751 Underlying: Common Stock · 5.1249 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.2768 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019162 · rdgdoc.xml · derivative · entry 5 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22.3098 Underlying: Common Stock · 4.2768 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.3357 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019162 · rdgdoc.xml · derivative · entry 4 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31.3287 Underlying: Common Stock · 3.3357 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.3357 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019162 · rdgdoc.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32.0117 Underlying: Common Stock · 3.3357 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6382 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019162 · rdgdoc.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24.0078 Underlying: Common Stock · 1.6382 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8606 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019162 · rdgdoc.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16.4748 Underlying: Common Stock · 0.8606 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.9776 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010275 · rdgdoc.xml · derivative · entry 7 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.9776 Underlying: Common Stock · 3.9776 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.9389 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010275 · rdgdoc.xml · derivative · entry 6 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.8502 Underlying: Common Stock · 4.9389 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.1217 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010275 · rdgdoc.xml · derivative · entry 5 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18.033 Underlying: Common Stock · 4.1217 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.2147 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010275 · rdgdoc.xml · derivative · entry 4 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27.993 Underlying: Common Stock · 3.2147 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.2147 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010275 · rdgdoc.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28.676 Underlying: Common Stock · 3.2147 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5788 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010275 · rdgdoc.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22.3696 Underlying: Common Stock · 1.5788 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8293 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010275 · rdgdoc.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15.6142 Underlying: Common Stock · 0.8293 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:17 UTC | PRECISION OPTICS CORPORATION, INC. POCI · Entity 7237 | GrantStock Options (Rights to buy) · Derivative | 15,000 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001683168-25-001797 · ownership.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2035-03-19 F2 · derivative.exercise_date: The options vest in two equal installments on June 29, 2025, and September 29, 2025, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:17 UTC | PRECISION OPTICS CORPORATION, INC. POCI · Entity 7237 | GrantStock Options (Rights to buy) · Derivative | 30,000 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001683168-25-001797 · ownership.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-03-19 F1 · derivative.exercise_date: The stock options are fully vested and exercisable at the time of grant. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006157 · rdgdoc.xml · derivative · entry 4 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.9113 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 203 | $91.85 | $18,645.55 |
DisclosureSEC source: 0001437749-25-006157 · rdgdoc.xml · nonDerivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,566 F4 · shares: These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 8, 2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006157 · rdgdoc.xml · nonDerivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 685 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006157 · rdgdoc.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,764 F1 · shares: These shares represent LMAT common stock acquired on February 28, 2025, upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years. F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-038386 · rdgdoc.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0553 Underlying: Common Stock · 17 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 169 | $92.12 | $15,568.28 |
DisclosureSEC source: 0001437749-24-038386 · rdgdoc.xml · nonDerivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,079 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-038386 · rdgdoc.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · derivative · entry 9 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24.7783 Underlying: Common Stock · 11 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · derivative · entry 8 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.4613 Underlying: Common Stock · 11 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 298 | $100.28 | $29,883.44 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · nonDerivative · entry 6 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,231 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units (PSU) awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 298 | $100.28 | $29,883.44 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · nonDerivative · entry 5 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,529 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · nonDerivative · entry 4 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · nonDerivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · derivative · entry 7 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20.7908 Underlying: Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 294 | $101.00 | $29,694.00 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · nonDerivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,805 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 11, 2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037502 · rdgdoc.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037270 · rdgdoc.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.9113 Underlying: Common Stock · 4 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 255 | $101.12 | $25,785.60 |
DisclosureSEC source: 0001437749-24-037270 · rdgdoc.xml · nonDerivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,081 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 8, 2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037270 · rdgdoc.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 9,577 | $0.00 Strike: $101.12 | $0.00 |
DisclosureSEC source: 0001437749-24-037134 · rdgdoc.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,577 Underlying: Common Stock · 9,577 shares Expires 2031-12-06 F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037134 · rdgdoc.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,332 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.5929 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037035 · rdgdoc.xml · derivative · entry 6 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.9113 Underlying: Common Stock · 3.5929 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1531 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037035 · rdgdoc.xml · derivative · entry 5 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35.7783 Underlying: Common Stock · 3.1531 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1531 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037035 · rdgdoc.xml · derivative · entry 4 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36.4613 Underlying: Common Stock · 3.1531 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.0636 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037035 · rdgdoc.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38.7908 Underlying: Common Stock · 2.0636 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.5426 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037035 · rdgdoc.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.7849 Underlying: Common Stock · 0.5426 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.576 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037035 · rdgdoc.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19.0553 Underlying: Common Stock · 0.576 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-036708 · rdgdoc.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.2423 Underlying: Common Stock · 12 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.